INOVIO PHARMACEUTICALS INC (INO) Stock Analyst Earnings Estimates
NASDAQ:INO - Nasdaq - US45773H4092 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.775M -76.05% | 10.262M 478.14% | 832K -91.89% | 126.755K -84.77% | 2.624M 1,970.14% | 26.828M 922.41% | 77.996M 190.73% | 143.39M 83.84% | 246.2M 71.70% | 330.47M 34.23% | 355.21M 7.49% | 407.02M 14.59% | |
| EBITDA YoY % growth | -297.658M -147.03% | -263.421M 11.50% | -130.66M 50.40% | -178.417M -36.55% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -301.218M -142.76% | -267.574M 11.17% | -133.427M 50.13% | -119.172M 10.68% | -111.104M 6.77% | -96.128M 13.48% | -62.42M 35.07% | -12.539M 79.91% | 82.985M 761.82% | 151.41M 82.45% | 201.72M 33.23% | 264.7M 31.22% | |
| Operating Margin | -16,970.03% | -2,607.43% | -16,036.90% | -94,017.21% | -4,234.13% | -358.31% | -80.03% | -8.74% | 33.71% | 45.82% | 56.79% | 65.03% | |
| EPS YoY % growth | -17.40 -31.82% | -14.16 18.62% | -6.16 56.50% | -4.25 31.00% | -2.95 30.65% | -2.12 28.21% | -1.98 6.60% | -0.55 72.40% | 1.11 302.78% | 2.45 121.92% | 2.73 11.32% | 3.50 28.10% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.85 24.52% | -0.73 44.10% | -0.67 43.56% | -0.57 36.45% | -0.56 33.69% |
| Revenue Q2Q % growth | 30.3K -70.48% | 101K | 101K 0.24% | 101K | 101K 233.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -26.228M 4.26% | -27.787M 11.74% | -28.434M 14.35% | -30.14M -10.21% | -32.275M -23.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.89 42.95% | -1.16 | 0.27 | 23.41% |
| Q2 2024 Q2Q % growth | -1.19 23.72% | -1.11 | -0.08 | -6.95% |
| Q1 2024 Q2Q % growth | -1.31 31.77% | -1.01 | -0.30 | -29.26% |
| Q4 2023 Q2Q % growth | -1.12 55.56% | -1.28 | 0.16 | 12.51% |
| Q3 2023 Q2Q % growth | -1.56 13.33% | -1.54 | -0.02 | -1.61% |
| Q2 2023 Q2Q % growth | -1.56 71.74% | -1.76 | 0.20 | 11.23% |
| Q1 2023 Q2Q % growth | -1.92 55.56% | -1.76 | -0.16 | -9.25% |
| Q4 2022 Q2Q % growth | -2.52 58.00% | -2.04 | -0.48 | -23.76% |
| Q3 2022 Q2Q % growth | -1.80 48.28% | -3.58 | 1.78 | 49.78% |
| Q2 2022 Q2Q % growth | -5.52 -17.95% | -3.78 | -1.74 | -46.13% |
| Q1 2022 Q2Q % growth | -4.32 -33.33% | -4.16 | -0.16 | -3.82% |
| Q4 2021 Q2Q % growth | -6.00 -257.14% | -3.86 | -2.14 | -55.24% |
| Q3 2021 Q2Q % growth | -3.48 -363.64% | -3.95 | 0.47 | 11.92% |
| Q2 2021 Q2Q % growth | -4.68 54.12% | -3.02 | -1.66 | -55.08% |
| Q1 2021 Q2Q % growth | -3.24 -22.73% | -2.20 | -1.04 | -47.34% |
| Q4 2020 Q2Q % growth | -1.68 63.16% | -2.69 | 1.01 | 37.62% |
| Q3 2020 Q2Q % growth | 1.32 144.00% | -2.29 | 3.61 | 157.70% |
| Q2 2020 Q2Q % growth | -10.20 -183.33% | -2.05 | -8.15 | -398.72% |
| Q1 2020 Q2Q % growth | -2.64 26.67% | -2.73 | 0.09 | 3.19% |
| Q4 2019 Q2Q % growth | -4.56 | -2.89 | -1.67 | -57.86% |
| Q3 2019 Q2Q % growth | -3.00 | -3.10 | 0.10 | 3.20% |
| Q2 2019 Q2Q % growth | -3.60 | -3.29 | -0.31 | -9.45% |
| Q1 2019 Q2Q % growth | -3.60 | -3.16 | -0.44 | -14.08% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -100.00% | 105.545K | -105.545K | -100.00% |
| Q2 2024 Q2Q % growth | 100.76K -55.41% | 122.715K | -21.955K | -17.89% |
| Q1 2024 Q2Q % growth | -100.00% | 152.308K | -152.308K | -100.00% |
| Q4 2023 Q2Q % growth | 102.65K -17.88% | 347.642K | -244.992K | -70.47% |
| Q3 2023 Q2Q % growth | 388K -95.76% | 117.837K | 270.163K | 229.27% |
| Q2 2023 Q2Q % growth | 225.97K -71.18% | 265.125K | -39.155K | -14.77% |
| Q1 2023 Q2Q % growth | 114K -42.71% | 277.75K | -163.75K | -58.96% |
| Q4 2022 Q2Q % growth | 125K -85.10% | 342.592K | -217.592K | -63.51% |
| Q3 2022 Q2Q % growth | 9.154M 3,034.93% | 629.402K | 8.525M | 1,354.40% |
| Q2 2022 Q2Q % growth | 784K 187.18% | 525.877K | 258.123K | 49.08% |
| Q1 2022 Q2Q % growth | 199K -46.36% | 678.387K | -479.387K | -70.67% |
| Q4 2021 Q2Q % growth | 839K -84.97% | 2.865M | -2.026M | -70.72% |
| Q3 2021 Q2Q % growth | 292K 23.73% | 980.377K | -688.377K | -70.22% |
| Q2 2021 Q2Q % growth | 273K 2.25% | 1.224M | -951K | -77.70% |
| Q1 2021 Q2Q % growth | 371K -72.04% | 863.691K | -492.691K | -57.04% |
| Q4 2020 Q2Q % growth | 5.581M 1,900.36% | 1.123M | 4.458M | 396.97% |
| Q3 2020 Q2Q % growth | 236K -72.78% | 3.077M | -2.841M | -92.33% |
| Q2 2020 Q2Q % growth | 267K 96.32% | 2.634M | -2.367M | -89.86% |
| Q1 2020 Q2Q % growth | 1.327M -53.11% | 1.932M | -605K | -31.31% |
| Q4 2019 Q2Q % growth | 279K | 2.344M | -2.065M | -88.10% |
| Q3 2019 Q2Q % growth | 867K | 3.967M | -3.1M | -78.14% |
| Q2 2019 Q2Q % growth | 136K | 5.722M | -5.586M | -97.62% |
| Q1 2019 Q2Q % growth | 2.83M | 6.47M | -3.64M | -56.26% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 8.26% | 16.13% | 2.76% | 9.55% |
| Revenue | 0% | -70.18% | 0% | -61.52% |